GLP-1 Therapy Cost in India (2026)
Brand-by-brand India price breakdowns for the three leading GLP-1 therapies. Each page covers dose-by-dose MRP, observed pharmacy pricing, Indian generic alternatives, and the hidden costs (consults, labs, needles) most patients don’t plan for.
Cost is one factor — fit is the other
The 5-minute Indian-guideline assessment helps you pick the right starting point.
Semaglutide · Novo Nordisk
Ozempic price in India 2026
Type 2 Diabetes
Monthly
₹5,660–5,800 – ₹9,100
Semaglutide · Novo Nordisk
Wegovy price in India 2026
Obesity (Chronic Weight Management)
Monthly
₹5,660 – ₹16,400
Tirzepatide · Eli Lilly
Mounjaro price in India 2026
Type 2 Diabetes + Obesity
Monthly
₹14,000 – ₹27,500
Prices reflect public MRP and observed pharmacy pricing as of May 2026. Actual pricing varies by city, pharmacy chain, and time. All brands listed are Schedule H drugs requiring a doctor’s prescription.
